Published 4 issues per year
ISSN Print: 0893-9675
ISSN Online: 2162-6448
Indexed in
Causes of Death Due to Hematological and Non-Hematological Cancers in 57 US Patients with Type 1 Gaucher Disease Who Were Never Treated with Enzyme Replacement Therapy
ABSTRACT
Patients with type 1 Gaucher disease (GD1) have increased risk of developing myeloma, other hematological cancers, hepatocellular carcinoma, and other solid tumors. Patient awareness of the GD1–cancer association causes anxiety and fear. Little is known about cancer as a cause of death in GD1, especially in patients never treated with GD1-specific therapies. Consequently, the effect of treatment on cancer mortality in GD1 patients is difficult to evaluate. In this review, starting with a population of 184 GD1 cases never treated, we annotate and analyze the causes of death of 57 GD1 patients who died of cancer. The proportional mortality ratio (PMR) for all malignancies in patients with GD1 is 1.57 (p = 0.0002), but it is much higher for myeloma (PMR = 9.66) and other hematological cancers, hepatocellular carcinoma, and kidney cancer (PMR = ≈4). However, deaths from colorectal and pancreatic cancers were not more frequent than expected, and deaths from lung, breast, gynecological, and prostate cancer occurred less than anticipated. Herein, we discuss whether GD1 is truly a hereditary cancer syndrome and the problem of comorbidities and cancer risk assessment, and we speculate as to whether the variability in death by cancer type might be attributable to biochemical sequelae of tumor cell and macrophage/stromal cell GBA1 mutation affecting signals for metastasis, the process most closely associated with cancer mortality.
-
Pavlova Elena V, Archer Joy, Z Wang Susan, Dekker Nick, Aerts Johannes MFG, Karlsson Stefan, Cox Timothy M, Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy, The Journal of Pathology, 235, 1, 2015. Crossref
-
Hollak Carla E. M., Wijburg Frits A., Treatment of lysosomal storage disorders: successes and challenges, Journal of Inherited Metabolic Disease, 37, 4, 2014. Crossref
-
Siebert Marina, Sidransky Ellen, Westbroek Wendy, Glucocerebrosidase is shaking up the synucleinopathies, Brain, 137, 5, 2014. Crossref
-
Cox Timothy M, Drelichman Guillermo, Cravo Renata, Balwani Manisha, Burrow Thomas Andrew, Martins Ana Maria, Lukina Elena, Rosenbloom Barry, Ross Leorah, Angell Jennifer, Puga Ana Cristina, Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial, The Lancet, 385, 9985, 2015. Crossref
-
Weinreb Neal J., Finegold David N., Feingold Eleanor, Zeng Zhen, Rosenbloom Barry E., Shankar Suma P., Amato Dominick, Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3), Orphanet Journal of Rare Diseases, 10, 1, 2015. Crossref
-
Cox T.M., Lysosomal Diseases, in Encyclopedia of Cell Biology, 2016. Crossref
-
Weinreb Neal J., Kaplan Paige, The history and accomplishments of the ICGG Gaucher registry, American Journal of Hematology, 90, 2015. Crossref
-
Utz Jeanine, Whitley Chester B., van Giersbergen Paul L.M., Kolb Stefan A., Comorbidities and pharmacotherapies in patients with Gaucher disease type 1: The potential for drug–drug interactions, Molecular Genetics and Metabolism, 117, 2, 2016. Crossref
-
Murugesan Vagishwari, Lischuk Andrew, Haims Andrew, Lackman Richard, Brooks John S., Mankin Henry, Mistry Pramod K., Case series and literature review of skeletal tumors and their incidence in the Gaucher disease population, American Journal of Hematology, 91, 7, 2016. Crossref
-
Nalysnyk Luba, Rotella Philip, Simeone Jason C., Hamed Alaa, Weinreb Neal, Gaucher disease epidemiology and natural history: a comprehensive review of the literature, Hematology, 22, 2, 2017. Crossref
-
Mistry Pramod K., Lopez Grisel, Schiffmann Raphael, Barton Norman W., Weinreb Neal J., Sidransky Ellen, Gaucher disease: Progress and ongoing challenges, Molecular Genetics and Metabolism, 120, 1-2, 2017. Crossref
-
Regenboog Martine, Bohte Anneloes E., Somers Inne, van Delden Otto M., Maas Mario, Hollak Carla E.M., Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease, Blood Cells, Molecules, and Diseases, 60, 2016. Crossref
-
Lal Tamanna Roshan, Borger Daniel K., Sidransky Ellen, Once again, rare diseases provide a spotlight, Molecular Genetics and Metabolism, 118, 1, 2016. Crossref
-
Regenboog Martine, van Kuilenburg André B.P., Verheij Joanne, Swinkels Dorine W., Hollak Carla E.M., Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications, Blood Reviews, 30, 6, 2016. Crossref
-
Hasiński Piotr, Bik-Multanowski Mirosław, Koba-Wszędobył Magdalena, Walczak Mieczysław, Bubnowski Marek, Milewska-Kranc Agnieszka, Smyk Andrzej, Machaczka Maciej, Choroba Gauchera – zalecenia dotyczące rozpoznawania, leczenia i monitorowania, Acta Haematologica Polonica, 48, 4, 2017. Crossref
-
Regenboog Martine, Bohte Anneloes E., Akkerman Erik M., Stoker Jaap, Hollak Carla E.M., Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment, British Journal of Haematology, 179, 4, 2017. Crossref
-
Regenboog Martine, van Dussen Laura, Verheij Joanne, Weinreb Neal J., Santosa David, vom Dahl Stephan, Häussinger Dieter, Müller Meike N., Canbay Ali, Rigoldi Miriam, Piperno Alberto, Dinur Tama, Zimran Ari, Mistry Pramod K., Salah Karima Yousfi, Belmatoug Nadia, Kuter David J., Hollak Carla E. M., Hepatocellular carcinoma in Gaucher disease: an international case series, Journal of Inherited Metabolic Disease, 41, 5, 2018. Crossref
-
Gary Sam E., Ryan Emory, Steward Alta M., Sidransky Ellen, Recent advances in the diagnosis and management of Gaucher disease, Expert Review of Endocrinology & Metabolism, 13, 2, 2018. Crossref
-
Degnan Andrew J., Ho-Fung Victor M., Ahrens-Nicklas Rebecca C., Barrera Christian A., Serai Suraj D., Wang Dah-Jyuu, Ficicioglu Can, Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement, Insights into Imaging, 10, 1, 2019. Crossref
-
Kumar Ashish, Acharya Subrat K., Singh Shivaram P., Arora Anil, Dhiman Radha K., Aggarwal Rakesh, Anand Anil C., Bhangui Prashant, Chawla Yogesh K., Datta Gupta Siddhartha, Dixit Vinod K., Duseja Ajay, Kalra Naveen, Kar Premashish, Kulkarni Suyash S., Kumar Rakesh, Kumar Manoj, Madhavan Ram, Mohan Prasad V.G., Mukund Amar, Nagral Aabha, Panda Dipanjan, Paul Shashi B., Rao Padaki N., Rela Mohamed, Sahu Manoj K., Saraswat Vivek A., Shah Samir R., Shalimar , Sharma Praveen, Taneja Sunil, Wadhawan Manav, 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations, Journal of Clinical and Experimental Hepatology, 10, 1, 2020. Crossref
-
Nair Shiny, Bar Noffar, Xu Mina L., Dhodapkar Madhav, Mistry Pramod K., Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy, Molecular Genetics and Metabolism, 129, 4, 2020. Crossref
-
Carubbi Francesca, Cappellini Maria Domenica, Fargion Silvia, Fracanzani Anna Ludovica, Nascimbeni Fabio, Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist, Digestive and Liver Disease, 52, 4, 2020. Crossref
-
Bonesteele Grant, Gargus J. Jay, Curtin Emily, Tang Mabel, Rosenbloom Barry, Kimonis Virginia, Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease, Molecular Genetics and Metabolism Reports, 25, 2020. Crossref
-
van Dussen Laura, Biegstraaten Marieke, Dijkgraaf Marcel GW, Hollak Carla EM, Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications, Orphanet Journal of Rare Diseases, 9, 1, 2014. Crossref
-
Adar Tomer, Ilan Yaron, Elstein Deborah, Zimran Ari, Liver involvement in Gaucher disease – Review and clinical approach, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref
-
Giraldo Pilar, Andrade-Campos Marcio, Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease, Journal of Blood Medicine, Volume 12, 2021. Crossref
-
Weinreb Neal J, Barbouth Deborah S, Lee Robert E, Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref
-
Cox Timothy M., Lysosomal Diseases, in Encyclopedia of Cell Biology, 2023. Crossref